These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 6060632)

  • 61. [Experience with a compound preparation in the treatment of cerebral blood circulation disorders in practice].
    Bremer C
    Z Allgemeinmed; 1970 Mar; 46(9):478-9. PubMed ID: 4399649
    [No Abstract]   [Full Text] [Related]  

  • 62. [On the therapy of cerebral and peripheral circulatory disorders].
    Klein L
    Med Welt; 1969 Aug; 35():1913-6. PubMed ID: 4390197
    [No Abstract]   [Full Text] [Related]  

  • 63. [Therapy of cerebral insufficiency in the practice].
    Göhring H
    Med Welt; 1968 Aug; 32():1737-40. PubMed ID: 4388458
    [No Abstract]   [Full Text] [Related]  

  • 64. Rheoencephalographic investigations regarding the effect of halidor on cerebral blood flow in ischaemia.
    Hadjiev D; Wassileva J
    Ther Hung; 1967; 15(4):165-7. PubMed ID: 5587379
    [No Abstract]   [Full Text] [Related]  

  • 65. [Effect of Viquidil on cerebral circulation. Studies using a scintillation camera-computer system].
    Hünermann B; Felix R; Wesener K; Winkler C
    Arzneimittelforschung; 1973 Aug; 23(8):1074-6. PubMed ID: 4801028
    [No Abstract]   [Full Text] [Related]  

  • 66. [Cerebral circulatory insufficiency. Value of a metabolic active drug].
    Girard PE; Boucher M
    Therapeutique; 1973; 49(5):397-400. PubMed ID: 4781833
    [No Abstract]   [Full Text] [Related]  

  • 67. Cerebral vasodilator therapy in stroke.
    McHenry LC
    Stroke; 1972; 3(6):686-91. PubMed ID: 4629450
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effects of vaso-active medications on cerebral circulation].
    Pratesi F; Corsi C; Tesi M; Spinelli P; Brunetti S; Caramelli L
    Cah Coll Med Hop Paris; 1968 Jul; 9(8):711-27. PubMed ID: 5683896
    [No Abstract]   [Full Text] [Related]  

  • 70. [Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1981 Feb; 125(6):228-34. PubMed ID: 7207673
    [No Abstract]   [Full Text] [Related]  

  • 71. [Results of 100 observations on the activity of 1035 M.D. in various neuro-psychiatric disorders due to cerebrovascular insufficiency].
    Digo R; Bellot JC
    Encephale; 1969; 58(3):267-82. PubMed ID: 5378185
    [No Abstract]   [Full Text] [Related]  

  • 72. How to use cerebral vasodilators and metabolic activators.
    Isozumi K; Izumi Y
    Tokai J Exp Clin Med; 1998 Oct; 23(4):187-92. PubMed ID: 10359509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Dyscirculatory encephalopathy].
    Shtok VN; Fedorova NV
    Sov Med; 1988; (11):99-101. PubMed ID: 3238527
    [No Abstract]   [Full Text] [Related]  

  • 74. [Clinical studies on the effect of a phospholipid complex from cattle brain in cerebral circulation disorders].
    Cloetens W; Cretallaz JC; Depaepe A; Bertholet G
    Med Welt; 1970 Mar; 12():510-5. PubMed ID: 5462778
    [No Abstract]   [Full Text] [Related]  

  • 75. [Problem of vasodilatation in the therapy of arterial diseases].
    Pratesi F; Caramelli L; Corsi C; Spinelli P; Tesi M
    Minerva Cardioangiol; 1973 Mar; 21(3):197-211. PubMed ID: 4708941
    [No Abstract]   [Full Text] [Related]  

  • 76. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 77. [Treatment of cerebral infarction in patients with hypertensive disease].
    Vinichuk SM
    Vrach Delo; 1976 Oct; (10):93-7. PubMed ID: 1022050
    [No Abstract]   [Full Text] [Related]  

  • 78. [Determinants estimating cerebral functions after long term therapy with hydergin].
    Herzfeld U; Christian W; Ronge J; Wittgen M
    Arztl Forsch; 1972 Jun; 26(6):215-28. PubMed ID: 4626216
    [No Abstract]   [Full Text] [Related]  

  • 79. [Use of vasoactive preparations with middle-aged and elderly patients with sequelae of cerebral circulatory disorders].
    Man'kovskiĭ NB; Kostiuchenko VG
    Vrach Delo; 1987 Apr; (4):51-5. PubMed ID: 3617640
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
    Florio F; Ruffolo S; Piro E
    Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.